1 |
Prebble, D. W., Holland, D. C., Robertson, L. P., Avery, V. M. and Carroll, A. R. (2020) Citronamine A, an antiplasmodial isoquinoline alkaloid from the australian marine sponge Citronia astra. Org. Lett. 22: 9574-9578.
DOI
|
2 |
Torres, J. P., Lin, Z., Fenton, D. S., Leavitt, L. U., Niu, C., Lam, P. Y., Robes, J. M., Peterson, R. T., Concepcion, G. P., Haygood, M. G., Olivera, B. M. and Schmidt, E. W. (2020) Boholamide A, an apd-class, hypoxia-selective cyclodepsipeptide. J. Nat. Prod. 83: 1249-1257.
DOI
|
3 |
McBrien, K. D., Berry, R. L., Lowe, S. E., Neddermann, K. M., Bursuker, I., Huang, S., Klohr, S. E. and Leet, J. E. (1995) Rakicidins, new cytotoxic lipopeptides from Micromonospora sp. fermentation, isolation and characterization. J. Antibiot. 48: 1446-1452.
DOI
|
4 |
Hamed, I., Ozogul, F., Ozogul, Y. and Regenstein, J. M. (2015) Marine bioactive compounds and their health benefits: a review. Compr. Rev. Food. Sci. F. 14: 446-465.
DOI
|
5 |
Lindequist, U. (2016) Marine-derived pharmaceuticals - challenges and opportunities. Biomol. Ther. 24: 561-571.
DOI
|
6 |
Hu, Y., Chen, J., Hu, G., Yu, J., Zhu, X., Lin, Y., Chen, S. and Yuan, J. (2015) Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012. Mar. Drugs 13: 202-221.
DOI
|
7 |
Guo, Y. W., Liu, X. J., Yuan, J., Li, H. J., Mahmud, T., Hong, M. J., Yu, J. C. and Lan, W. J. (2020) L-tryptophan induces a marine-derived fusarium sp. to produce indole alkaloids with activity against the zika virus. J. Nat. Prod. 83: 3372-3380.
DOI
|
8 |
Fangzhi, H., Guangju, L., Xuhai, Z., Yahui, D., Liang, W., Yijing, W., Yue, C., and Quan, Z. (2021) Total synthesis and structure revision of boholamide A. Org. Lett. 23: 4976-4980.
DOI
|
9 |
Abdelmohsen, U. R., Szesny, M., Othman, E. M., Schirmeister, T., Grond, S., Stopper, H. and Hentschel, U. (2012) Antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115. Mar. Drugs 10: 2208-2221.
DOI
|
10 |
Demirkiran, O., Almaliti, J., Leao, T., Navarro, G., Byrum, T., Valeriote, F. A., Gerwick, L. and Gerwick, W. H. (2021) Portobelamides A and B and caciqueamide, cytotoxic peptidic natural products from a caldora sp. marine cyanobacterium. J. Nat. Prod. 84: 2081-2093.
DOI
|
11 |
Solanki, R., Khanna, M. and Lal, R. (2008) Bioactive compounds from marine actinomycetes. Indian J. Microbiol. 48: 410-431.
DOI
|
12 |
Mayer, A. M. and Hamann, M. T. (2005) Marine pharmacology in 2001-2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol C. Toxicol. Pharmacol. 140: 265-286.
DOI
|
13 |
Subramani, R. and Aalbersberg, W. (2012) Marine actinomycetes: an ongoing source of novel bioactive metabolites. Microbiol. Res. 167: 571-580.
DOI
|
14 |
Fenical, W. and Jensen, P. R. (2006) Developing a new resource for drug discovery: marine actinomycete bacteria. Nat. Chem. Biol. 2: 666-673.
DOI
|
15 |
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. and Prinsep, M. R. (2012) Marine natural products. Nat. Prod. Rep. 29: 144-222.
DOI
|